XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
BUSINESS OVERVIEW AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)
12 Months Ended
Dec. 31, 2021
Segment
tranche
commercial_product
Significant Accounting Policies [Line Items]  
Number of commercial products in portfolio | commercial_product 7
Number of tranches in offering period | tranche 4
Span of offering period 24 months
Number of reportable segment 1
Number of operating segments 1
Aldurazyme | Minimum  
Significant Accounting Policies [Line Items]  
Payment received as percentage of net product sales 39.50%
Aldurazyme | Maximum  
Significant Accounting Policies [Line Items]  
Payment received as percentage of net product sales 50.00%